Search
Invivyd Inc
IVVDAdd to Watchlist
1.020USD
+0.265+35.10%
Close 09-21 16:00（ET）
294.76MMarket Cap
LossP/E TTM
Pre-market 05:35 (ET)0.981USD-0.039-3.82%
Pre-market 05:35 (ET)About {index_name} Invivyd Inc Company
Invivyd, Inc. is a biopharmaceutical company. The Company’s proprietary INVYMAB platform approach combines state-of-the-art viral surveillance and predictive modeling with advanced antibody engineering. INVYMAB is designed to facilitate the rapid, serial generation of new monoclonal antibodies (mAbs) to keep pace with evolving viral threats. The Company delivers antibody-based therapies that protect vulnerable people from the devastating consequences of circulating viral threats, such as SARS-CoV-2. Its PEMGARDA (pemivibart) is the Company's first mAb to receive regulatory authorization and is designed to keep pace with SARS-CoV-2 viral evolution. PEMGARDA is used for the pre-exposure prophylaxis (prevention) of COVID-19 in adults and adolescents. Its VYD2311 is optimized for neutralization potency against SARS-CoV-2 lineages such as BA.2.86 and JN.1. The Company also has additional anti-SARS-CoV-2 mAb candidates in discovery and pre-clinical characterization.
Invivyd Inc Profile
Ticker SymbolIVVD
Company nameInvivyd Inc
IPO dateAug 06, 2021
CEO- -
Number of employees99
Security typeOrdinary Share
Fiscal year-endAug 06
Address209 Church Street
CityNEW HAVEN
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code06510
Phone17818190080
Websitehttps://invivyd.com/
Ticker SymbolIVVD
IPO dateAug 06, 2021
CEO- -
Company Executives of Invivyd Inc
Name
Name/Position
Position
Shareholding
Change
Ms. Jill Andersen, J.D.
Ms. Jill Andersen, J.D.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
284.27K
+35.89%
Ms. Julie Green
Ms. Julie Green
Chief Human Resources Officer
Chief Human Resources Officer
168.94K
+36.24%
Mr. Kevin F. McLaughlin
Mr. Kevin F. McLaughlin
Independent Director
Independent Director
50.00K
--
Mr. Terrance G. (Terry) McGuire
Mr. Terrance G. (Terry) McGuire
Independent Director
Independent Director
--
--
Mr. Ajay G. Royan
Mr. Ajay G. Royan
Lead Independent Director
Lead Independent Director
--
--
Mr. Marc Elia
Mr. Marc Elia
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Tamsin Berry
Ms. Tamsin Berry
Independent Director
Independent Director
--
--
Ms. Christine Lindenboom
Ms. Christine Lindenboom
Independent Director
Independent Director
--
--
Mr. William Duke, Jr.
Mr. William Duke, Jr.
Chief Financial Officer, Principal Accounting Officer
Chief Financial Officer, Principal Accounting Officer
--
--
Mr. Robert Allen, Ph.D.
Mr. Robert Allen, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Ms. Jill Andersen, J.D.
Ms. Jill Andersen, J.D.
Chief Legal Officer and Corporate Secretary
Chief Legal Officer and Corporate Secretary
284.27K
+35.89%
Ms. Julie Green
Ms. Julie Green
Chief Human Resources Officer
Chief Human Resources Officer
168.94K
+36.24%
Mr. Kevin F. McLaughlin
Mr. Kevin F. McLaughlin
Independent Director
Independent Director
50.00K
--
Mr. Terrance G. (Terry) McGuire
Mr. Terrance G. (Terry) McGuire
Independent Director
Independent Director
--
--
Mr. Ajay G. Royan
Mr. Ajay G. Royan
Lead Independent Director
Lead Independent Director
--
--
Mr. Marc Elia
Mr. Marc Elia
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
FAQs
Who are the top five shareholders of Invivyd Inc?
The top five shareholders of Invivyd Inc are: Ms. Jill Andersen, J.D.
How many institutions hold shares of Invivyd Inc (IVVD)?
As of 2026Q1, 257 institutions hold shares of Invivyd Inc, with a combined market value of approximately 272.04M, accounting for 96.20% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 41027945.00.